• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加蓬东南部迪恩加农村无症状个体中高水平的特异性抗裂殖子IgG1抗体

High Level of Specific Anti- Merozoite IgG1 Antibodies in Rural Asymptomatic Individuals of Dienga, South-Eastern Gabon.

作者信息

Pegha-Moukandja Irène, Imboumy-Limoukou Roméo-Karl, Tchitoula-Makaya Nina, Mouinga-Ondeme Augustin-Ghislain, Biteghe-Bi-Essone Jean Claude, Mba Dieudonne Nkoghe, Lekana-Douki Jean-Bernard, Ndouo Fousseyni S Toure

机构信息

Centre International de Recherches Médicales de Franceville (CIRMF), BP 769, Franceville Gabon, Africa.

Département de Parasitologie-Mycologie et Médecine Tropicale, Faculté de Médecine, Université des Sciences de la Santé, BP 4009, Libreville, Gabon, Africa.

出版信息

Eur J Microbiol Immunol (Bp). 2017 Dec 4;7(4):247-260. doi: 10.1556/1886.2017.00010. eCollection 2017 Dec 18.

DOI:10.1556/1886.2017.00010
PMID:29403652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5793693/
Abstract

merozoite antigens (PfMAgs) play an essential role in the development of immunity to malaria. Currently, protein 113 (Pf 113), apical membrane antigen 1 (AMA1), erythrocyte binding antigens (EBA175), and reticulocyte binding protein homologue 5 (RH5) are among the most PfMAgs studied. A comparative analysis of naturally acquired antibodies against these antigens in children would increase our knowledge about the development of protective immunity. Analysis of antibodies to Pf113, PfAMA1, PfEBA175, and PfRH5 was conducted in rural population during 2013 and 2014. Both prevalence and levels of total IgG anti-PfAMA1 were higher than that of IgG anti-PfEBA175, anti-PfRH5, and anti-Pf113. Seroconversion to PfAMA1 and PfEBA175 occurred moderately in young children and reached to the maximum in adolescent and in adults. High prevalence of IgG anti-Pf113 was observed in young children of 3 to 6 years old in 2013. The four antigens were recognized by IgG 1, 2, 3, and 4 antibodies from a large proportion of the subjects, and all of them induced high levels of specific IgG1 against PfAMA1, PfEBA175, fewer by Pf113 and PfRH5. Many asymptomatic children had specific IgG1 recognizing multiple antigens, and these IgG1 antibodies could be associated with a reduced risk of developing malaria symptoms.

摘要

裂殖子抗原(PfMAgs)在疟疾免疫发展中起关键作用。目前,蛋白113(Pf 113)、顶膜抗原1(AMA1)、红细胞结合抗原(EBA175)和网织红细胞结合蛋白同源物5(RH5)是研究最多的PfMAgs。对儿童中针对这些抗原的自然获得性抗体进行比较分析,将增加我们对保护性免疫发展的了解。2013年至2014年期间,对农村人口中针对Pf113、PfAMA1、PfEBA175和PfRH5的抗体进行了分析。抗PfAMA1的总IgG流行率和水平均高于抗PfEBA175、抗PfRH5和抗Pf113。幼儿中向PfAMA1和PfEBA175的血清转化适度发生,并在青少年和成年人中达到最高。2013年,在3至6岁的幼儿中观察到抗Pf113的高流行率。很大一部分受试者的IgG 1、2、3和4抗体识别这四种抗原,并且所有这些抗体都诱导产生了高水平的针对PfAMA1、PfEBA175的特异性IgG1,针对Pf113和PfRH5的较少。许多无症状儿童具有识别多种抗原的特异性IgG1,并且这些IgG1抗体可能与疟疾症状发生风险降低有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/f0584f81ccb4/eujmi-07-247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/26af999d93a9/eujmi-07-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/f6e8486f5aa7/eujmi-07-247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/803a9003c8f7/eujmi-07-247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/d53cd67189a6/eujmi-07-247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/5d5bdb8df742/eujmi-07-247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/f0584f81ccb4/eujmi-07-247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/26af999d93a9/eujmi-07-247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/f6e8486f5aa7/eujmi-07-247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/803a9003c8f7/eujmi-07-247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/d53cd67189a6/eujmi-07-247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/5d5bdb8df742/eujmi-07-247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc4/5793693/f0584f81ccb4/eujmi-07-247-g006.jpg

相似文献

1
High Level of Specific Anti- Merozoite IgG1 Antibodies in Rural Asymptomatic Individuals of Dienga, South-Eastern Gabon.加蓬东南部迪恩加农村无症状个体中高水平的特异性抗裂殖子IgG1抗体
Eur J Microbiol Immunol (Bp). 2017 Dec 4;7(4):247-260. doi: 10.1556/1886.2017.00010. eCollection 2017 Dec 18.
2
Comparative Antibody Responses Against three Antimalarial Vaccine Candidate Antigens from Urban and Rural Exposed Individuals in Gabon.加蓬城市和农村暴露个体针对三种抗疟候选疫苗抗原的抗体反应比较
Eur J Microbiol Immunol (Bp). 2016 Nov 3;6(4):287-297. doi: 10.1556/1886.2016.00027. eCollection 2016 Dec 1.
3
Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria.加纳儿童恶性疟原虫感染中 PfRH5 复合物抗原抗体反应的动力学。
PLoS One. 2018 Jun 8;13(6):e0198371. doi: 10.1371/journal.pone.0198371. eCollection 2018.
4
Immunoglobulin response to the low polymorphic Pf113 antigen in children from Lastoursville, South-East of Gabon.加蓬东南部拉斯图尔维尔儿童对低多态性Pf113抗原的免疫球蛋白反应。
Acta Trop. 2016 Nov;163:149-56. doi: 10.1016/j.actatropica.2016.08.014. Epub 2016 Aug 12.
5
Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.恶性疟原虫裂殖子表面抗原特异性细胞亲合 IgG 与贝宁出生队列中疟疾感染的控制。
Malar J. 2019 Jun 11;18(1):194. doi: 10.1186/s12936-019-2831-x.
6
Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.尼日利亚拉各斯人群疟原虫红细胞结合蛋白同源物 5 候选疫苗中的遗传多态性。
Malar J. 2020 Jan 6;19(1):6. doi: 10.1186/s12936-019-3096-0.
7
Pattern of antibody responses to Plasmodium falciparum antigens in individuals differentially exposed to Anopheles bites.个体对疟原虫抗原抗体反应模式与按蚊叮咬的不同暴露程度相关。
Malar J. 2020 Feb 21;19(1):83. doi: 10.1186/s12936-020-03160-5.
8
Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara.1期随机对照试验,评估重组毕赤酵母表达的恶性疟原虫顶端膜抗原1(PfAMA1-FVO [25-545])在班迪亚加拉健康马里成年人中的安全性和免疫原性。
Malar J. 2016 Aug 30;15(1):442. doi: 10.1186/s12936-016-1466-4.
9
Association of antibodies to Plasmodium falciparum reticulocyte binding protein homolog 5 with protection from clinical malaria.恶性疟原虫网织红细胞结合蛋白同源物5抗体与临床疟疾防护的关联
Front Microbiol. 2014 Jun 30;5:314. doi: 10.3389/fmicb.2014.00314. eCollection 2014.
10
Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.伊朗疟疾低流行地区自然暴露个体对恶性疟原虫顶端膜抗原1和裂殖子表面蛋白1的IgG亚类特异性反应谱的比较分析。
Malar J. 2015 Feb 5;14:58. doi: 10.1186/s12936-015-0547-0.

引用本文的文献

1
The role of naturally acquired antimalarial antibodies in subclinical Plasmodium spp. infection.天然获得的抗疟抗体在亚临床疟原虫感染中的作用。
J Leukoc Biol. 2022 May;111(5):1097-1105. doi: 10.1002/JLB.5MR1021-537R. Epub 2022 Jan 20.
2
IgG antibody response against Plasmodium falciparum aminopeptidase 1 antigen in Gabonese children living in Makokou and Franceville.冈比亚儿童和法国儿童对恶性疟原虫氨肽酶 1 抗原的 IgG 抗体反应
Clin Exp Immunol. 2020 Jun;200(3):287-298. doi: 10.1111/cei.13425. Epub 2020 Feb 21.

本文引用的文献

1
Comparative Antibody Responses Against three Antimalarial Vaccine Candidate Antigens from Urban and Rural Exposed Individuals in Gabon.加蓬城市和农村暴露个体针对三种抗疟候选疫苗抗原的抗体反应比较
Eur J Microbiol Immunol (Bp). 2016 Nov 3;6(4):287-297. doi: 10.1556/1886.2016.00027. eCollection 2016 Dec 1.
2
Marked Rise in the Prevalence of Asymptomatic Plasmodium falciparum Infection in Rural Gabon.加蓬农村地区无症状恶性疟原虫感染率显著上升。
PLoS One. 2016 May 26;11(5):e0153899. doi: 10.1371/journal.pone.0153899. eCollection 2016.
3
Designing malaria vaccines to circumvent antigen variability.
设计疟疾疫苗以规避抗原变异性。
Vaccine. 2015 Dec 22;33(52):7506-12. doi: 10.1016/j.vaccine.2015.09.110. Epub 2015 Nov 1.
4
Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials.RTS,S/AS疟疾疫苗的临床开发:对I-III期临床试验的系统评价
Future Microbiol. 2015;10(10):1553-78. doi: 10.2217/fmb.15.90. Epub 2015 Oct 6.
5
Whole organism blood stage vaccines against malaria.针对疟疾的全生物体血液阶段疫苗。
Vaccine. 2015 Dec 22;33(52):7469-75. doi: 10.1016/j.vaccine.2015.09.057. Epub 2015 Oct 1.
6
New antigens for a multicomponent blood-stage malaria vaccine.一种多组分血液期疟疾疫苗的新抗原。
Sci Transl Med. 2014 Jul 30;6(247):247ra102. doi: 10.1126/scitranslmed.3008705.
7
Dynamics of the antibody response to Plasmodium falciparum infection in African children.非洲儿童对恶性疟原虫感染的抗体反应动态
J Infect Dis. 2014 Oct 1;210(7):1115-22. doi: 10.1093/infdis/jiu219. Epub 2014 Apr 8.
8
Plasmodium falciparum erythrocyte invasion: combining function with immune evasion.恶性疟原虫红细胞入侵:功能与免疫逃避的结合
PLoS Pathog. 2014 Mar 20;10(3):e1003943. doi: 10.1371/journal.ppat.1003943. eCollection 2014 Mar.
9
Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria.天然产生的针对恶性疟原虫红细胞结合蛋白同源物 5 的抗体可抑制寄生虫生长,并可预测对疟疾的保护作用。
J Infect Dis. 2014 Mar 1;209(5):789-98. doi: 10.1093/infdis/jit553. Epub 2013 Oct 16.
10
Breadth of anti-merozoite antibody responses is associated with the genetic diversity of asymptomatic Plasmodium falciparum infections and protection against clinical malaria.抗裂殖体抗体反应的广度与无症状疟原虫感染的遗传多样性以及对临床疟疾的保护有关。
Clin Infect Dis. 2013 Nov;57(10):1409-16. doi: 10.1093/cid/cit556. Epub 2013 Aug 27.